NasdaqCM - Nasdaq Real Time Price USD
Sol-Gel Technologies Ltd. (SLGL)
7.80
+0.26
+(3.38%)
At close: May 20 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -2.3 | -10.1 | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -1.75 | -1.6 | -1.9 | -0.5 |
| EPS Actual | -1.7 | -2.3 | 0.7 | -0.1 |
| Difference | 0.05 | -0.7 | 2.6 | 0.4 |
| Surprise % | 2.86% | -43.75% | 136.84% | 80.00% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | 1 | -- |
| Up Last 30 Days | -- | 1 | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SLGL | -- | -- | -- | -- |
| S&P 500 | 13.32% | 2.69% | 7.77% | 13.75% |
Upgrades & Downgrades
| Downgrade | Raymond James: Strong Buy to Outperform | 8/19/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/22/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/20/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/13/2023 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 8/14/2023 |
| Maintains | Raymond James: Strong Buy to Strong Buy | 8/11/2023 |
Related Tickers
ARTL Artelo Biosciences, Inc.
0.9664
+6.50%
MLEC Moolec Science SA
9.00
0.00%
ENTO Entero Therapeutics, Inc.
0.4310
+3.88%
ENVB Enveric Biosciences, Inc.
1.3500
-0.74%
ANTX AN2 Therapeutics, Inc.
1.1900
0.00%
PXMD PaxMedica, Inc.
0.0001
0.00%
XBIO Xenetic Biosciences, Inc.
3.0400
+1.67%
CYCC Cyclacel Pharmaceuticals, Inc.
1.7500
-12.50%
GLTO Galecto, Inc.
3.0600
-0.33%
SNPX Synaptogenix, Inc.
2.2900
+2.23%